Egetis Therapeutics AB (publ) P0F.SG Stock
Egetis Therapeutics AB (publ) Price Chart
Egetis Therapeutics AB (publ) P0F.SG Financial and Trading Overview
| Egetis Therapeutics AB (publ) stock price | 0.52 EUR |
| Previous Close | 0.43 EUR |
| Open | 0.42 EUR |
| Bid | 0.46 EUR x 0 |
| Ask | 0.49 EUR x 0 |
| Day's Range | 0.42 - 0.46 EUR |
| 52 Week Range | 0.27 - 0.76 EUR |
| Volume | 0 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | 117.16M EUR |
| Beta (5Y Monthly) | 1.260153 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.12 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
P0F.SG Valuation Measures
| Enterprise Value | 92.1M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.8291592 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Egetis Therapeutics AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.260153 |
| 52-Week Change | 57.46% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.76 EUR |
| 52 Week Low | 0.27 EUR |
| 50-Day Moving Average | 0.6 EUR |
| 200-Day Moving Average | 0.48 EUR |
P0F.SG Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 249.59M |
| Float | 144.21M |
| Short Ratio | N/A |
| % Held by Insiders | 52.07% |
| % Held by Institutions | 17.19% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -25.032% |
| Return on Equity (ttm) | -42.54% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | -4.20% |
| Gross Profit (ttm) | -120000000 EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.09 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | 0.6 EUR |
| Current Ratio (mrq) | 6.801 |
| Book Value Per Share (mrq) | 0.559 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Egetis Therapeutics AB (publ)
| Country | Germany |
| State | N/A |
| City | Stockholm |
| Address | Klara Norra Kyrkogata 26 |
| ZIP | 111 22 |
| Phone | 46 86 79 72 10 |
| Website | https://www.egetis.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 20 |
Egetis Therapeutics AB (publ), a pharmaceutical drug development company, focuses on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment. Its products pipeline includes Aladote, a drug to reduce the risk of acute liver injury associated with acetaminophen/paracetamol poisoning, which is in phase IIb/III clinical trial; and Emcitate, a drug for the treatment of MCT8 deficiency, a rare inborn error of thyroid hormone signaling that is in phase IIb/III clinical trial. The company was formerly known as PledPharma AB (publ) and changed its name to Egetis Therapeutics AB (publ) in December 2020. Egetis Therapeutics AB (publ) was incorporated in 2006 and is based in Stockholm, Sweden.
Q&A For Egetis Therapeutics AB (publ) Stock
What is a current P0F.SG stock price?
Egetis Therapeutics AB (publ) P0F.SG stock price today per share is 0.52 EUR.
How to purchase Egetis Therapeutics AB (publ) stock?
You can buy P0F.SG shares on the Stuttgart exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Egetis Therapeutics AB (publ)?
The stock symbol or ticker of Egetis Therapeutics AB (publ) is P0F.SG.
Which industry does the Egetis Therapeutics AB (publ) company belong to?
The Egetis Therapeutics AB (publ) industry is Biotechnology.
How many shares does Egetis Therapeutics AB (publ) have in circulation?
The max supply of Egetis Therapeutics AB (publ) shares is 297.17M.
What is Egetis Therapeutics AB (publ) Price to Earnings Ratio (PE Ratio)?
Egetis Therapeutics AB (publ) PE Ratio is now.
What was Egetis Therapeutics AB (publ) earnings per share over the trailing 12 months (TTM)?
Egetis Therapeutics AB (publ) EPS is -0.12 EUR over the trailing 12 months.
Which sector does the Egetis Therapeutics AB (publ) company belong to?
The Egetis Therapeutics AB (publ) sector is Healthcare.